RecruitingNot ApplicableNCT05557526

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation


Sponsor

Evangelical Hospital Düsseldorf

Enrollment

60 participants

Start Date

Jun 9, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • symptomatic atrial fibrillation
  • indication for pulmonary vein isolation
  • sufficient command of the German language

Exclusion Criteria6

  • age <18 years
  • permanent atrial fibrillation
  • presence of psychiatric disorders which impair the study participitatin
  • presence of another medical condiction which influences quality of life stronger than the cardiac condition
  • atrial fibrillation induced by intoxication, medicamentation or infection
  • inability to grap the course of the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExpectation optimization

A short (2-5 min) verbal intervention will be createad individually based on the expectation of the patient towards the procedure.


Locations(2)

Evangelic Hospital Düsseldorf

Düsseldorf, North Rhine-Westfalia, Germany

Westdeutsches Herz- und Gefäßzentrum

Essen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05557526


Related Trials